Jane Solomons, MD
Interventional Pain Medicine · Lansing, MINPI 1184158701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Boston Scientific at 58.5% of the total. Reporting peaked in 2022 at $647 and has fallen 70.1% since, to $193 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MI, where the typical reported total is $2,071.
Across 19 payments — averaging $59.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$664
- Curonix LLC$142
- MML US, Inc.$135
- Medtronic$110
- Merck$41
- Si-bone, Inc.$29
- plus $15 from 1 others
What the payments were for
- Food & beverage$1,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $664 |
| Curonix LLC | 1 | $142 |
| MML US, Inc. | 1 | $135 |
| Medtronic | 1 | $110 |
| Merck | 2 | $41 |
| Si-bone, Inc. | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,135 in reported general payments places this provider in the 40th percentile of 88 interventional pain medicine providers in Michigan.
See all interventional pain medicine providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 15 | $344 |
| Meloxicam | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Lansing
- Richard FerroLansing$31K
- Narasimha GundamrajLansing$5K
- Kevin OrrLansing$2K
- Malani GuptaLansing$2K
- Subhash GuptaLansing$959
- Ryan PollinaSaint Clair Shores$144K
- Ariel MajjhooMonroe$124K
- Chad BrummettAnn Arbor$109K
- Anand ThakurClinton Township$102K
- Evan PeskinFlint$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.